Shigeoka, T., Nomiyama, T., Kawanami, T., Hamaguchi, Y., Horikawa, T., Tanaka, T., Irie, S., Motonaga, R., Hamanoue, N., Tanabe, M., et al
While anecdotal reports and preliminary research suggest a potential connection between GLP-1 medications and decreased alcohol consumption, these agents are not FDA-approved for treating alcohol use disorder
Its a synthetic 15-amino-acid chain based on a fragment of a protein found in gastric juice, and that origin gives it an unusual property: its stable in the acidic conditions of the stomach
OPTIMAL DX MEMBERS CLICK HERE to learn more about GLP-1, phytochemicals, health benefits, etc.
Chemical Formula: CHNO Molecular Weight: 4845.444 g/mol CAS Number: 2381089-83-2 Purity: typically 9599%, verified through analytical testing Supplied as 60 mg lyophilized peptide in sealed vials Structural modifications: fatty acid conjugation and C-terminal amidation Intended for laboratory investigation of metabolic signaling pathways For research use only How is Retatrutide (60 mg) synthesized